A Phase 2, Randomized, Dose-Response Trial of Taprenepag Isopropyl (PF-04217329) Versus Latanoprost 0.005% in Open-Angle Glaucoma and Ocular Hypertension

By Schachar Ronald A.   Raber Susan   Courtney Rachel   Zhang Min  

Current Eye Research, Vol. 36, Iss. 9, 2011-09 ,pp. : 809-817

Informa Healthcare

Access to resources Recommend Favorite

Ocular Surface Disease in Patients with Ocular Hypertension and Glaucoma

By Stewart William C.   Stewart Jeanette A.   Nelson Lindsay A.  

Current Eye Research, Vol. 36, Iss. 5, 2011-05 ,pp. : 391-398

Informa Healthcare

Access to resources Recommend Favorite

The Response of Retrobulbar Vasculature to Hypercapnia in Primary Open-Angle Glaucoma and Ocular Hypertension

By  

Ophthalmic Research, Vol. 39, Iss. 2, 2007-02 ,pp. : 76-80

Karger

Access to resources Recommend Favorite

A Comparison of Latanoprost Monotherapy With a Combination Therapy of Timolol/Dorzolamide in Patients With Primary Open-Angle Glaucoma

By  

Annals of Ophthalmology, Vol. 38, Iss. 2, 2006-06 ,pp. : 111-116

Humana Press, Inc

Access to resources Recommend Favorite

Efficacy of Latanoprost Additive Therapy on Uncontrolled Glaucoma

By  

Ophthalmologica, Vol. 216, Iss. 6, 2003-01 ,pp. : 443-448

Karger

Access to resources Recommend Favorite